Needham starts TetraLogic Pharma at Buy

|About: TetraLogic Pharmaceuticals ... (TLOG)|By:, SA News Editor

Recently public TetraLogic Pharmaceuticals (TLOG +4%) trades higher in early action.

Helping the cause is Needham's Chad Messer, who has initiated the shares at Buy with a $16 price target.

TLOG "is now developing birinapant as a best-in-class IAP inhibitor with a well established safety profile in multiple indications for cancer and infectious disease," Messer notes.